August 2025 in “Journal of the American Academy of Dermatology” The reported treatment depths were likely incorrect and could risk patient safety.
December 2005 in “Journal of Medical Regulation” Australia improved medical education and Canada focused on professionalism and patient safety.
26 citations
,
March 2015 in “American journal of clinical dermatology” Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.
207 citations
,
January 2011 in “Dermatologic Therapy” Laser hair removal is the most requested cosmetic procedure and has become a scientifically-based treatment suitable for all skin types.
22 citations
,
July 2003 in “PubMed” Finasteride 1 mg significantly improves hair growth in men aged 41 to 60 with male pattern hair loss.
15 citations
,
April 2002 in “PubMed” Finasteride effectively treats male pattern hair loss without serious side effects.
8 citations
,
August 2016 in “Expert opinion on pharmacotherapy” New, safer treatments for children's hair disorders are needed, and better evaluation methods are recommended.
5 citations
,
April 2025 in “Journal of the American Academy of Dermatology” Use minoxidil correctly and be aware of side effects for best hair loss treatment results.
1 citations
,
November 2018 in “Dermatologic Therapy” Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.
September 2025 in “Journal of Cosmetic Dermatology” Scalp micropigmentation effectively treats localized alopecia with high patient satisfaction.
May 2025 in “LUMEN ET VIRTUS” Nursing care is crucial for safe and effective hair transplants.
July 2023 in “Journal of Clinical Medicine” Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.
20 citations
,
December 2003 in “Journal of Cosmetic and Laser Therapy” An 800nm diode laser safely and effectively reduces hair for about 8 months, with most patients satisfied and few side effects.
15 citations
,
January 2015 in “Dermatitis” Topical immunotherapy is the best treatment for severe alopecia areata.
April 2026 in “Journal of the American Academy of Dermatology” Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.
January 2022 in “SSRN Electronic Journal” Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.
April 2015 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.
42 citations
,
January 1998 in “BioDrugs” Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.
21 citations
,
March 2018 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” 5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.
15 citations
,
October 2017 in “Journal of Cosmetic and Laser Therapy” FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.
5 citations
,
October 1993 in “International Journal of Dermatology” Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.
July 2025 in “Journal of Cosmetic Dermatology” Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.
September 2024 in “Journal of Cutaneous and Aesthetic Surgery” Bicalutamide may help treat female pattern hair loss.
June 2024 in “Journal of Clinical Medicine” Hair dye can cause severe scalp burns and long-term health risks, so safety guidelines must be followed.
March 2021 in “Clin-Alert” The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.
July 2017 in “Skin appendage disorders” Platelet-Rich Plasma (PRP) is becoming popular for treating hair loss and it's important for dermatologists to understand how it works and its safety.
3 citations
,
March 2019 in “PubMed” Biofibre hair implants are safe, well-tolerated, and provide immediate cosmetic improvement for hair loss.
September 2025 in “Headache The Journal of Head and Face Pain” The ACP's migraine treatment guidelines are flawed and don't prioritize patient safety.
January 2016 in “Georg Thieme Verlag eBooks” Facelift surgery has evolved to focus on natural results and safety, with patient selection and postoperative care being key to success.
25 citations
,
March 2000 in “Journal of Endocrinological Investigation” Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.